Cargando…

SUN-237 Higher Doses of Testosterone Gel Required in Hypogonadal Men with Obesity to Achieve Therapeutic Replacement - Advice on Dose Titration

Introduction: Testosterone (T) gel is one of the most widely used treatment options for hypogonadal men. Our clinical practice has shown that a great percentage of men achieve therapeutic T levels 3 weeks after the commencement of T gel. This achievement depends on the initiation dose of T gel which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mumdzic, Enis, Morganti, Emma, Gowda, Siri, Rao, Preethi, Jones, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553410/ http://dx.doi.org/10.1210/js.2019-SUN-237

Ejemplares similares

SAT-030 The Barnsley Diabetes Hypogonadal Questionnaire (BDHQ) - Validation for the Clinical Use to Support the Diagnosis of Testosterone Deficiency in Men with Type 2 Diabetes (T2D)
por: Mumdzic, Enis, et al.
Publicado: (2020)

RF34 | PMON263 Study of Testosterone Replacement in Hypogonadal Men With Uncontrolled Type 2 Diabetes – a Randomised Double Blinded Placebo Controlled Trial (STRIDE Study)
por: Mohan Rao, Preethi, et al.
Publicado: (2022)

SAT-051 Effects of Testosterone Replacement on Glycemic Control and Other Cardiovascular Risk Factors in Hypogonadal Men with Uncontrolled Type 2 Diabetes (Stride Study): Design, Implementation and Baseline Data
por: Rao, Preethi Mohan, et al.
Publicado: (2020)

SAT-LB6 First Human Trial of an Oral Native Testosterone Shows Physiological Levels of Testosterone and Dht in Both Fasted and Fed State in Hypogonadal Men
por: Newell-Price, John D C, et al.
Publicado: (2020)

SUN-234 Effect of Testosterone Undecanoate on Metabolic Syndrome Parameters in a Cohort of Hypogonadism
por: Yadav, Subhash Chandra, et al.
Publicado: (2019)

SUN-222 Testosterone Treatment in Men with Classical vs. Functional Hypogonadism: A 9-Year Registry
por: Zitzmann, Michael, et al.
Publicado: (2019)

SUN-220 The Effect of Testosterone Nasal Gel on Reproductive Hormones and Semen Parameters
por: Masterson, Thomas, et al.
Publicado: (2019)

SUN-LB043 Phase 2 Randomized Study of the Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Hypogonadism
por: Tishova, Yuliya, et al.
Publicado: (2019)

SUN-221 Effects of Liraglutide on Obesity-Associated Functional Hypogonadism in Men: A Randomized, Testosterone Replacement Treatment-Controlled Study
por: Jensterle Sever, Mojca, et al.
Publicado: (2019)

PMON268 A Multicenter, Open Label, Variable Dose, Two-Arm, Pilot Paediatric Phase 1 Pk Study To Evaluate 4.5% Testosterone Nasal Gel In Hypogonadal Boys
por: Lucas-Herald, Angela, et al.
Publicado: (2022)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
por: DelConte, Anthony, et al.
Publicado: (2022)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

SUN-LB037 Encephalitis as a Cause of Acquired Hypogonadotropic Hypogonadism
por: Lubrano Heinsen, Antonio, et al.
Publicado: (2019)

SUN-027 Testicular Regression Syndrome, an Underdiagnosed Cause of Hypergonadotropic Hypogonadism
por: Canales-Ramos, Nicolle M, et al.
Publicado: (2020)

SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men as a Potential Mechanism to Improve Atherosclerosis
por: Bateman, Lauren, et al.
Publicado: (2020)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

PMON264 TESTOSTERONE IMPROVES QUALITY OF LIFE, SEXUAL FUNCTION AND DELAYED VERBAL RECALL- RANDOMISED PLACEBO-CONTROLLED STUDY IN HYPOGONADAL MEN WITH UNCONTROLLED TYPE 2 DIABETES – STRIDE STUDY
por: Rao, Preethi Mohan, et al.
Publicado: (2022)

PMON265 First Ever Placebo-Controlled Randomised Study of Testosterone on Ambulatory Blood Pressure and Heart Rate in Hypogonadal Men With Uncontrolled Type 2 Diabetes – STRIDE Study
por: Mohan Rao, Preethi, et al.
Publicado: (2022)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

SUN-217 Alternate Pathways of Testosterone Action in Testis
por: Talapatra, Arpita
Publicado: (2019)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy
por: Graziani, Andrea, et al.
Publicado: (2023)

SUN-209 Clinical Hypogonadism Related to Incidentally Discovered Adrenal Insufficiency: Case Report
por: Darquea Leoro, Andres, et al.
Publicado: (2019)

SUN-039 Estradiol Dose and Concentrations in Transfeminine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

SUN-206 Acute Cardiovascular Complications FromTestosterone Therapy
por: Shakir, Mohamed, et al.
Publicado: (2019)

SUN-229 The Role of Testosterone in Spermatogenesis: Lessons from Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
por: Grande, Giuseppe, et al.
Publicado: (2019)

SUN-228 Opioid Use Is Not Associated with Clinical Hypogonadism in Men with Chronic Non-Cancer Pain
por: Sarlos, Stella, et al.
Publicado: (2019)

SUN-233 Testosterone Ordering Processes in a Military Health System
por: Beauvais, Alexis, et al.
Publicado: (2019)

PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
por: Jayasena, Channa N, et al.
Publicado: (2022)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020)

SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020)

PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)
por: Swerdloff, Ronald, et al.
Publicado: (2022)

LBMON237 Predictors Of Postmenarchal Progression Of Pcos Phenotypes In At-risk Girls
por: Torchen, Laura C, et al.
Publicado: (2022)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009)

OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023)

SUN-032 Digenic Inheritance of PCSK1 and CHD7 Mutations in PAX4 Homozygous Diabetic Male with Normosmic Hypogonadotropic Hypogonadism
por: Cho, Yun Kyung, et al.
Publicado: (2020)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o1qb3npt6eo5s0fdvq596cq0f9